衰弱对老年急性缺血性卒中血管内治疗结局的影响
这项回顾性队列研究纳入198例≥70岁接受血管内治疗(EVT)的急性缺血性卒中(AIS)患者,用临床衰弱量表(CFS)评估衰弱(CFS>3为衰弱)。校正年龄、NIHSS和干预时间后,CFS与90天不良功能结局独立相关(aOR 1.54,95%CI 1.04-2.28,P=0.032);衰弱患者出院后照护需求更高(91.6% vs 72.8%,P=0.002),死亡率有升高趋势但未达统计学显著(18.3% vs 9.6%,P=0.080)。
要点
- ≥70岁AIS患者接受EVT前用CFS评估衰弱,CFS>3定义为衰弱。
- 校正年龄、NIHSS和干预时间后,CFS与90天不良功能结局独立相关(aOR 1.54)。
- 衰弱患者出院后照护需求显著更高(91.6% vs 72.8%,P=0.002)。
核心结论
- 在≥70岁接受EVT的AIS患者中,衰弱与90天较差功能结局相关。
研究设计与样本
- 单中心回顾性队列研究,连续纳入≥70岁接受EVT的AIS患者共198例,平均年龄78.1岁,女性占52.0%。
- 以CFS 1-3定义为非衰弱,CFS>3定义为衰弱。
主要发现
- 衰弱患者年龄更大、女性更多、共病更多。
- 校正年龄、NIHSS和干预时间后,CFS与不良功能结局显著相关(aOR 1.54,95%CI 1.04-2.28,P=0.032)。
- 衰弱患者死亡率有升高趋势(18.3% vs 9.6%,P=0.080)。
- 衰弱患者出院后照护需求更高(91.6% vs 72.8%,P=0.002)。
- 其他次要结局(住院时长、院内死亡、成功再灌注、症状性颅内出血、出血转化)无显著差异。
关键数值与推荐
- 衰弱定义:CFS>3为衰弱,CFS 1-3为非衰弱。
- 主要结局:90天改良Rankin量表(mRS)评分。
- CFS与不良功能结局的校正OR为1.54(95%CI 1.04-2.28,P=0.032)。
临床怎么用
- 对≥70岁拟行EVT的AIS患者,可用CFS快速识别衰弱,辅助预后沟通与照护规划。
- 衰弱患者出院后照护需求高,应提前安排出院后照护支持。
局限性
- 单中心回顾性队列研究,样本量198例。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: frailty has been shown to be a better predictor of clinical outcomes than age alone across many diseases. Few studies have examined the relationship between frailty, stroke and stroke interventions such as endovascular thrombectomy (EVT). OBJECTIVE: we aimed to investigate the impact of frailty measured by clinical frailty scale (CFS) on clinical outcomes after EVT for acute ischemic stroke (AIS) in older patients ≥70 years. METHODS: in this retrospective cohort study, we included all consecutive AIS patients age ≥ 70 years receiving EVT at a single comprehensive stroke centre. Patients with CFS of 1-3 were defined as not frail, and CFS > 3 was defined as frail. The primary outcome was modified Rankin Score (mRS) at 90 days. The secondary outcomes included duration of hospitalisation, in-hospital mortality, carer requirement, successful reperfusion, symptomatic intracranial haemorrhage and haemorrhagic transformation. RESULTS: a total of 198 patients were included. The mean age was 78.1 years and 52.0% were female. Frail patients were older, more likely to be female, had more co-morbidities. CFS was significantly associated with poor functional outcome after adjustment for age, NIHSS and time to intervention (adjusted odds ratio [aOR] 1.54, 95% confidence interval [CI] 1.04-2.28, P = 0.032). There was trend towards higher mortality rate in frail patients (frail: 18.3%; non-frail: 9.6%; P = 0.080). There were no significant differences in other secondary outcomes except increased carer requirement post discharge in frail patients (frail: 91.6%; non-frail: 72.8%; P = 0.002). CONCLUSIONS: frailty was associated with poorer functional outcome at 90 days post-EVT in patients ≥ 70 years.
引用
- Tan BYQ, Ho JSY, Leow AS, et al. Effect of frailty on outcomes of endovascular treatment for acute ischaemic stroke in older patients. Age Ageing. 2022. PMID: 35486669. doi:10.1093/ageing/afac096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。